Paritaprevir

Chemical formula: C₄₀H₄₃N₇O₇S  Molecular mass: 765.89 g/mol  PubChem compound: 68498031

Therapeutic indications

Paritaprevir is indicated for:

Chronic hepatitis C

Population group: only adults (18 - 65 years old)

at least one of
Chronic type C viral hepatitis
Hepatitis C virus

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Paritaprevir is contraindicated in the following cases:

Contraindication

17 alpha-Ethinylestradiol

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈